Drug Shortage Report for REVATIO
| Report ID | 110817 |
| Drug Identification Number | 02341611 |
| Brand name | REVATIO |
| Common or Proper name | Revatio |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | SILDENAFIL |
| Strength(s) | 0.8MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1x 12.5ml Vial |
| ATC code | C02KX |
| ATC description | OTHER ANTIHYPERTENSIVES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2020-04-02 |
| Estimated end date | 2020-08-07 |
| Actual end date | 2020-08-06 |
| Shortage status | Resolved |
| Updated date | 2020-08-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2020-08-07 | French | Compare |
| v12 | 2020-08-07 | English | Compare |
| v11 | 2020-07-21 | French | Compare |
| v10 | 2020-07-21 | French | Compare |
| v9 | 2020-07-21 | English | Compare |
| v8 | 2020-07-06 | French | Compare |
| v7 | 2020-07-06 | English | Compare |
| v6 | 2020-06-08 | French | Compare |
| v5 | 2020-06-08 | English | Compare |
| v4 | 2020-05-25 | French | Compare |
| v3 | 2020-05-25 | English | Compare |
| v2 | 2020-04-03 | French | Compare |
| v1 | 2020-04-03 | English | Compare |
Showing 1 to 13 of 13